Literature DB >> 11345947

An open trial of risperidone augmentation of partial response to clozapine.

C G Taylor, S W Flynn, S Altman, T Ehmann, G W MacEwan, W G Honer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11345947     DOI： 10.1016/s0920-9964(00)00104-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  11 in total

1.  Aripiprazole augmentation of clozapine: in refractory schizophrenia.

Authors:  Adam Keller Ashton
Journal:  Psychiatry (Edgmont)       Date:  2005-02

Review 2.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 5.  Risperidone augmentation of clozapine: a critical review.

Authors:  Vassilis P Kontaxakis; Panayotis P Ferentinos; Beata J Havaki-Kontaxaki; Konstantinos G Paplos; Dimitra A Pappa; George N Christodoulou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-08       Impact factor: 5.270

6.  Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Authors:  Marc Ziegenbein; Georg Wittmann; Stefan Kropp
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

7.  Concept and Management of Treatment Resistant Schizophrenia (TRS).

Authors:  Nitesh Painuly; Nitin Gupta; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

8.  Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.

Authors:  Hye Jin Choi; Seung Ho Jung; Min Hee Kang; Jeong Seop Lee; Jae Nam Bae; Chul Eung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

9.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

10.  Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.

Authors:  Felice Iasevoli; Elisabetta F Buonaguro; Massimo Marconi; Emanuela Di Giovambattista; Maria Paola Rapagnani; Domenico De Berardis; Giovanni Martinotti; Monica Mazza; Raffaele Balletta; Nicola Serroni; Massimo Di Giannantonio; Andrea de Bartolomeis; Alessandro Valchera
Journal:  ISRN Pharmacol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.